Company: INV
Filing Date: 2025-04-29
Form Type: PRE 14A
Source: 0001628280-25-020657
Chunk: 20

Company: Innventure, Inc.
Filing Date: 2025-04-29
Form: PRE 14A
Chunk 20
---
 & Asia driving international business expansions. Mr. Brown currently serves on the board of Magnera

Corporation, a global manufacturing company (NYSE: MAGN), and has previously served on the board of Nokia

Corporation, a Finnish telecommunications, information technology, and consumer electronics corporation (NYSE: NOK),

where, after 11 years and upon reaching the tenure limit, he concluded his term in 2023. Formerly, Mr. Brown was a

director of Medpace Holdings, Inc. (Nasdaq: MEDP) from 2016 to 2019. Mr. Brown was appointed in 2011 by the

Government of Singapore as a member of the board of directors of the Agency for Science, Technology, and Research

(ASTAR), giving him experience on how to operate within and through government agencies across the globe. Mr. Brown

has also served on the board of directors of Xavier University in Cincinnati, Ohio. Mr. Brown has a B.S. in Chemical

Engineering from the Polytechnic Institute of New York University, and an MBA in Marketing and Finance from Xavier

University. The Company believes that Mr. Brown is well qualified to serve as a member of the Board due to his

organizational leadership development and years of experience as a public company director.

**Class III Directors**

Michael (“Mike”) Otworth , 63, is Innventure’s Executive Chairman and a Class III director. Mr. Otworth has

served as Executive Chairman of Innventure LLC since 2015. Mr. Otworth was the Founding CEO and Chairman of the

Board of PureCycle, an innovative plastic waste processing company, from 2015 to 2022. Mr. Otworth and team took PCT

from an early-stage concept to an operational pilot and funded its first commercial plant, followed by a successful public

offering in March of 2021. Prior to Innventure, Mr. Otworth served as President and Founding Partner of Green Ocean

Innovation, a company that provided technology sourcing, innovation strategy, and development services to Lilly/Elanco

Animal Health, from 2008 to 2015. Mr. Otworth also served as Vice-President and Founding CEO of multiple start-ups at

XLTG from 1996 to 2000. Mr. Otworth began his career on Capitol Hill working as a legislative aide and committee staff

member in the U.S. House of Representatives. The Company believes